Acanthosis nigricans
☆ Yng nghanlyniadau Stiftung Warentest 2022 o’r Almaen, roedd boddhad defnyddwyr â ModelDerm ond ychydig yn is nag ymgynghoriadau telefeddygaeth taledig.
Mae'n gyffredin mewn pobl ordew.
References
Mae Acanthosis nigricans yn amlygiad croenol o gyflwr gwaelodol. Mae'n aml yn ymddangos mewn plygiadau croen fel y gwddf, y ceseiliau a'r werddyr, yn edrych fel darnau tywyll melfedaidd gydag ymylon aneglur. Mae'r cyflwr hwn fel arfer yn gysylltiedig â diabetes ac ymwrthedd i inswlin, ond mewn achosion prin, gallai bwyntio at ganser y tu mewn i'r corff. Gallai hefyd ymddangos oherwydd problemau hormonau neu gymryd meddyginiaethau penodol fel steroidau a phils rheoli geni.
Acanthosis nigricans is a cutaneous manifestation of an underlying condition. It usually develops in skin folds, such as the back of the neck, axilla, and groin, where it presents as velvety hyper-pigmented patches with poorly defined borders. Acanthosis nigricans is most commonly associated with diabetes and insulin resistance, but rarely it can be a sign of internal malignancy. It can also occur with hormone disorders or with the use of certain medications like systemic glucocorticoids and oral contraceptives.
Acanthosis nigricans is a cutaneous manifestation of an underlying condition. It usually develops in skin folds, such as the back of the neck, axilla, and groin, where it presents as velvety hyper-pigmented patches with poorly defined borders. Acanthosis nigricans is most commonly associated with diabetes and insulin resistance, but rarely it can be a sign of internal malignancy. It can also occur with hormone disorders or with the use of certain medications like systemic glucocorticoids and oral contraceptives.
Mae Acanthosis nigricans (AN) yn gyflwr croen cyffredin sy'n gysylltiedig â materion iechyd amrywiol fel ymwrthedd i inswlin, diabetes, gordewdra, rhai mathau o ganser, problemau hormonaidd, ac adweithiau i feddyginiaethau. Mae trin AN yn canolbwyntio ar fynd i'r afael â'r problemau iechyd sylfaenol. I ddechrau, mae meddygon yn gwirio am arwyddion o syndrom ymwrthedd inswlin, sy'n cynnwys gordewdra, colesterol uchel, pwysedd gwaed uchel, a diabetes math 2. Mae meddygon yn aml yn rhagnodi topical retinoids fel y dewis cyntaf o driniaeth, a all helpu i dewychu'r croen. Fodd bynnag, efallai na fyddant yn mynd i'r afael yn llawn â thywyllu croen. Mae angen cymhwyso opsiynau triniaeth eraill (salicylic acid, podophyllin, urea, calcipotriol) yn aml hefyd.
Acanthosis nigricans (AN) is a common dermatologic manifestation of systemic disease that is associated with insulin resistance, diabetes mellitus, obesity, internal malignancy, endocrine disorders, and drug reactions. Treatment of AN primarily focuses on resolution of the underlying disease processes causing the velvety, hyperpigmented, hyperkeratotic plaques found on the skin. Initial considerations for the AN workup include evaluating patients for insulin resistance syndrome characterized by obesity, dyslipidemia, hypertension, and diabetes mellitus type II. For cosmetic treatment, topical retinoids are considered the first-line therapy for insulin-resistant AN by modifying keratinization rate. However, topical tretinoin requires application for long durations and improves hyperkeratosis, but not hyperpigmentation. Topical salicylic acid, podophyllin, urea, and calcipotriol also require frequent application, while TCA peels may provide a faster and less time-intense burden.
Acanthosis nigricans (AN) is a common dermatologic manifestation of systemic disease that is associated with insulin resistance, diabetes mellitus, obesity, internal malignancy, endocrine disorders, and drug reactions. Treatment of AN primarily focuses on resolution of the underlying disease processes causing the velvety, hyperpigmented, hyperkeratotic plaques found on the skin. Initial considerations for the AN workup include evaluating patients for insulin resistance syndrome characterized by obesity, dyslipidemia, hypertension, and diabetes mellitus type II. For cosmetic treatment, topical retinoids are considered the first-line therapy for insulin-resistant AN by modifying keratinization rate. However, topical tretinoin requires application for long durations and improves hyperkeratosis, but not hyperpigmentation. Topical salicylic acid, podophyllin, urea, and calcipotriol also require frequent application, while TCA peels may provide a faster and less time-intense burden.
○ Achosion
Mae'n digwydd fel arfer mewn unigolion iau na 40 oed, gall fod wedi'i etifeddu'n enetig ac mae'n gysylltiedig â gordewdra neu endocrinopathi, fel hypothyroidiaeth, acromegali, clefyd ofari polycystig, diabetes sy'n gwrthsefyll inswlin neu glefyd Cushing.
○ Triniaeth ― OTC Drugs
#40% urea cream